Popular baby product causes cancer – is it available in Israel?

Johnson & Johnson has proposed up to $5.5 billion to settle lawsuits related to talc products, including Johnson's Baby Powder, which may cause ovarian cancer. The agreement covers about 69,000 claims. In Israel, the product was sold until 2023, and local consumers are not covered by the U.S. compensation, but a class action lawsuit is underway in Israel.

Johnson & Johnson has proposed allocating up to $5.5 billion to settle tens of thousands of lawsuits in the U.S. related to talc products, including Johnson's Baby Powder. Plaintiffs claim the product may cause ovarian cancer. The agreement covers about 69,000 claims. The first payment of $3 billion is scheduled for 2027. The company stopped selling talc powder in the U.S. and Canada in 2020, but in Israel the product was sold until 2023. The brand's Israeli website still states the powder contains natural talc. Israeli consumers are not covered by the U.S. agreement, but a class action lawsuit has been ongoing in Israel since 2018. Talc is mined near asbestos deposits, raising concerns about contamination. The company's vice president denied the allegations.